anmelden
FTSE All-Share
5.735,46
PKT
+15,93
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.05.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 05.05.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 04.05.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 04.05.22 | Rio Tinto Outperform | Credit Suisse Group | |
| 04.05.22 | BP Buy | UBS AG | |
| 04.05.22 | BP Buy | Deutsche Bank AG | |
| 04.05.22 | Unilever Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.22 | BP Overweight | Barclays Capital | |
| 04.05.22 | HSBC Overweight | Barclays Capital | |
| 03.05.22 | HSBC Buy | UBS AG | |
| 03.05.22 | BP Overweight | JP Morgan Chase & Co. | |
| 03.05.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 03.05.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.05.22 | BP Outperform | RBC Capital Markets | |
| 03.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 02.05.22 | HSBC Buy | Goldman Sachs Group Inc. | |
| 29.04.22 | Barclays Outperform | Credit Suisse Group | |
| 29.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.22 | Unilever Sell | UBS AG | |
| 29.04.22 | Prudential Overweight | JP Morgan Chase & Co. | |
| 29.04.22 | GSK Equal Weight | Barclays Capital | |
| 29.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.22 | Unilever Market-Perform | Bernstein Research | |
| 29.04.22 | Barclays Hold | Deutsche Bank AG | |
| 29.04.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 28.04.22 | GSK Hold | Deutsche Bank AG | |
| 28.04.22 | GSK Underperform | Credit Suisse Group | |
| 28.04.22 | BAT Overweight | JP Morgan Chase & Co. | |
| 28.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.04.22 | Barclays Sector Perform | RBC Capital Markets | |
| 28.04.22 | Unilever Sector Perform | RBC Capital Markets | |
| 28.04.22 | Barclays Buy | UBS AG | |
| 28.04.22 | Barclays Buy | Goldman Sachs Group Inc. | |
| 28.04.22 | Unilever Sell | UBS AG | |
| 28.04.22 | GSK Neutral | UBS AG | |
| 28.04.22 | Barclays Neutral | JP Morgan Chase & Co. | |
| 28.04.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.04.22 | HSBC Neutral | Credit Suisse Group |